CONMED Corporation
CNMD
$57.08
-$0.67-1.16%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 321.26M | 345.94M | 316.70M | 332.10M | 312.27M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 321.26M | 345.94M | 316.70M | 332.10M | 312.27M |
| Cost of Revenue | 140.10M | 147.60M | 137.71M | 148.37M | 138.71M |
| Gross Profit | 181.15M | 198.34M | 179.00M | 183.73M | 173.57M |
| SG&A Expenses | 144.85M | 131.42M | 126.73M | 131.22M | 129.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 297.90M | 292.19M | 277.99M | 293.69M | 282.16M |
| Operating Income | 23.36M | 53.75M | 38.71M | 38.41M | 30.11M |
| Income Before Tax | 7.67M | 43.64M | 56.46M | 37.51M | 25.42M |
| Income Tax Expenses | 1.64M | 9.89M | 7.47M | 7.54M | 5.71M |
| Earnings from Continuing Operations | 6.04M | 33.76M | 48.98M | 29.98M | 19.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.04M | 33.76M | 48.98M | 29.98M | 19.71M |
| EBIT | 23.36M | 53.75M | 38.71M | 38.41M | 30.11M |
| EBITDA | 41.61M | 70.36M | 56.68M | 56.25M | 48.15M |
| EPS Basic | 0.19 | 1.09 | 1.59 | 0.97 | 0.64 |
| Normalized Basic EPS | 0.30 | 0.91 | 0.60 | 0.58 | 0.42 |
| EPS Diluted | 0.19 | 1.08 | 1.57 | 0.96 | 0.63 |
| Normalized Diluted EPS | 0.30 | 0.90 | 0.59 | 0.58 | 0.41 |
| Average Basic Shares Outstanding | 30.97M | 30.92M | 30.86M | 30.81M | 30.78M |
| Average Diluted Shares Outstanding | 31.15M | 31.15M | 31.11M | 31.11M | 31.27M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
| Payout Ratio | 102.39% | 18.30% | 12.58% | 20.54% | 31.22% |